IN8bio, Inc.
INAB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $413 | $1,236 | $1,453 | $2,473 |
| - Cash | $11 | $21 | $18 | $37 |
| + Debt | $5 | $5 | $6 | $2 |
| Enterprise Value | $407 | $1,220 | $1,441 | $2,439 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$3 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$27 | -$28 | -$27 | -$14 |
| % Margin | – | – | – | – |
| Net Income | -$30 | -$30 | -$29 | -$15 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.57 | -1 | -1.36 | -0.78 |
| % Growth | 43% | 26.5% | -74.4% | – |
| Operating Cash Flow | -$24 | -$23 | -$24 | -$14 |
| Capital Expenditures | -$0 | -$1 | -$4 | -$0 |
| Free Cash Flow | -$24 | -$24 | -$28 | -$14 |